Pharmacology Tildrakizumab was approved by FDA in 2018 for A Cystic fibrosis B Migraine C Hypeension D Psoriasis 💡 Explanation Tildrakizumab was approved by FDA in 2018 for ✓ Correct Answer: D. Psoriasis